Financials
Financial year 2024
Institute for Dermatologic Innovation from Ukkel, company number BE1008257887, closed financial year 2024 with a result of € 114,855 after tax. For that financial year Institute for Dermatologic Innovation recorded a gross margin of € 158,739 and equity of € 119,855. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ 119,855
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 114,855
Profit after tax over the fiscal year.
€ 6,928
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 114,855.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 11,411
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 6,427
Supplier invoices still open on the last day of the fiscal year.
€ 36,415
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Institute for Dermatologic Innovation?
What happened at Institute for Dermatologic Innovation in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 114,855. filed late Source: NBB ↗
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 31,763 in corporate taxes since 2024.
A new publication or filing at Institute for Dermatologic Innovation? We notify you, reason included.
Follow Institute for Dermatologic InnovationDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Institute for Dermatologic Innovation is Ievgeniia Pastushenko.
Directors
According to the 2024 annual accounts
Ievgeniia Pastushenko
Director
Establishments
Establishment units
Physical locations of this company
De Frélaan 35
1180 Ukkel
De Frélaan 35 box A
1180 Ukkel
Active since 10 April 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1008.257.887
- VAT number
- BE 1008.257.887
- Registered office
- De Frélaan 35, 1180 Ukkel
- Names & denominations
- Institute for Dermatologic Innovation · IDI
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 April 2024
- Peppol
- Active · Active since 16 Jul 2025
- Activities · NACE
Activiteiten van medisch specialisten